These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 7954262

  • 1. Implantation and growth of epidermal growth factor (EGF) receptor expressing human ovarian cancer xenografts in nude mice is dependent on EGF.
    Kurachi H, Morishige K, Adachi H, Adachi K, Tasaka K, Sawada M, Miyake A.
    Cancer; 1994 Dec 01; 74(11):2984-90. PubMed ID: 7954262
    [Abstract] [Full Text] [Related]

  • 2. Importance of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vivo.
    Kurachi H, Morishige K, Amemiya K, Adachi H, Hirota K, Miyake A, Tanizawa O.
    Cancer Res; 1991 Nov 01; 51(21):5956-9. PubMed ID: 1933859
    [Abstract] [Full Text] [Related]

  • 3. Growth inhibition of human ovarian cancers by cytotoxic analogues of luteinizing hormone-releasing hormone.
    Miyazaki M, Nagy A, Schally AV, Lamharzi N, Halmos G, Szepeshazi K, Groot K, Armatis P.
    J Natl Cancer Inst; 1997 Dec 03; 89(23):1803-9. PubMed ID: 9392622
    [Abstract] [Full Text] [Related]

  • 4. The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer.
    Bartlett JM, Langdon SP, Simpson BJ, Stewart M, Katsaros D, Sismondi P, Love S, Scott WN, Williams AR, Lessells AM, Macleod KG, Smyth JF, Miller WR.
    Br J Cancer; 1996 Feb 03; 73(3):301-6. PubMed ID: 8562334
    [Abstract] [Full Text] [Related]

  • 5. Expression of gonadotropin-releasing hormone receptor in human epithelial ovarian carcinoma.
    Imai A, Ohno T, Ohsuye K, Tamaya T.
    Ann Clin Biochem; 1994 Nov 03; 31 ( Pt 6)():550-5. PubMed ID: 7880073
    [Abstract] [Full Text] [Related]

  • 6. mRNA phenotyping of the major ligands and receptors of the EGF supergene family in human ovarian epithelial cells.
    Gordon AW, Pegues JC, Johnson GR, Kannan B, Auersperg N, Stromberg K.
    Cancer Lett; 1995 Feb 10; 89(1):63-71. PubMed ID: 7882303
    [Abstract] [Full Text] [Related]

  • 7. Evidence for the involvement of transforming growth factor alpha and epidermal growth factor receptor autocrine growth mechanism in primary human ovarian cancers in vitro.
    Morishige K, Kurachi H, Amemiya K, Fujita Y, Yamamoto T, Miyake A, Tanizawa O.
    Cancer Res; 1991 Oct 01; 51(19):5322-8. PubMed ID: 1717146
    [Abstract] [Full Text] [Related]

  • 8. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.
    Tanaka Y, Miyamoto S, Suzuki SO, Oki E, Yagi H, Sonoda K, Yamazaki A, Mizushima H, Maehara Y, Mekada E, Nakano H.
    Clin Cancer Res; 2005 Jul 01; 11(13):4783-92. PubMed ID: 16000575
    [Abstract] [Full Text] [Related]

  • 9. Expression of messenger ribonucleic acid and presence of immunoreactive proteins for epidermal growth factor (EGF), transforming growth factor alpha (TGF alpha) and EGF/TGF alpha receptors and 125I-EGF binding sites in human fallopian tube.
    Chegini N, Zhao Y, McLean FW.
    Biol Reprod; 1994 May 01; 50(5):1049-58. PubMed ID: 8025160
    [Abstract] [Full Text] [Related]

  • 10. The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migration.
    Dong Y, He Y, de Boer L, Stack MS, Lumley JW, Clements JA, Hooper JD.
    J Biol Chem; 2012 Mar 23; 287(13):9792-9803. PubMed ID: 22315226
    [Abstract] [Full Text] [Related]

  • 11. Epidermal growth factor and transforming growth factor alpha mRNA expression in human breast cancer biopsies; analysis in relation to estradiol, progesterone and EGF receptor content.
    Artagaveytia N, Le Penven S, Falette N, Lucero R, Garófalo EG, Saez S.
    J Steroid Biochem Mol Biol; 1997 Feb 23; 60(3-4):221-8. PubMed ID: 9191980
    [Abstract] [Full Text] [Related]

  • 12. Abrogation of cisplatin-induced programmed cell death in human breast cancer cells by epidermal growth factor antisense RNA.
    Dixit M, Yang JL, Poirier MC, Price JO, Andrews PA, Arteaga CL.
    J Natl Cancer Inst; 1997 Mar 05; 89(5):365-73. PubMed ID: 9060958
    [Abstract] [Full Text] [Related]

  • 13. Decrease in the level and mRNA expression of LH-RH and EGF receptors after treatment with LH-RH antagonist cetrorelix in DU-145 prostate tumor xenografts in nude mice.
    Lamharzi N, Halmos G, Jungwirth A, Schally AV.
    Int J Oncol; 1998 Sep 05; 13(3):429-35. PubMed ID: 9683774
    [Abstract] [Full Text] [Related]

  • 14. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.
    Halmos G, Schally AV.
    Proc Natl Acad Sci U S A; 1997 Feb 04; 94(3):956-60. PubMed ID: 9023364
    [Abstract] [Full Text] [Related]

  • 15. Epidermal growth factor modulates claudins and tight junctional functions in ovarian cancer cell lines.
    Ogawa M, Kojima T, Someya M, Nomura K, Takasawa A, Murata M, Tanaka S, Saito T, Sawada N.
    Histochem Cell Biol; 2012 Aug 04; 138(2):323-38. PubMed ID: 22544349
    [Abstract] [Full Text] [Related]

  • 16. Correlation between epidermal growth factor receptor concentration and the growth of human gastric cancer xenografts in nude mice.
    Kiyama T, Onda M, Tokunaga A, Fujita I, Okuda T, Mizutani T, Yoshiyuki T, Shimizu Y, Nishi K, Matsukura N.
    Gastroenterol Jpn; 1992 Aug 04; 27(4):459-65. PubMed ID: 1526429
    [Abstract] [Full Text] [Related]

  • 17. Effect of sialoadenectomy on medroxyprogesterone-acetate-induced mammary carcinogenesis in BALB/c mice. Correlation between histology and epidermal-growth-factor receptor content.
    Kordon EC, Guerra F, Molinolo AA, Elizalde P, Charreau EH, Pasqualini CD, Montecchia F, Pazos P, Dran G, Lanari C.
    Int J Cancer; 1994 Oct 15; 59(2):196-203. PubMed ID: 7927919
    [Abstract] [Full Text] [Related]

  • 18. Silencing of CXCR4 blocks progression of ovarian cancer and depresses canonical Wnt signaling pathway.
    Wang J, Cai J, Han F, Yang C, Tong Q, Cao T, Wu L, Wang Z.
    Int J Gynecol Cancer; 2011 Aug 15; 21(6):981-7. PubMed ID: 21738044
    [Abstract] [Full Text] [Related]

  • 19. Serum levels of epidermal growth factor, transforming growth factor, and c-erbB2 in ovarian cancer.
    Balcan E, Demirkiran F, Aydin Y, Sanioglu C, Bese T, Arvas M, Akçay T, Cift T.
    Int J Gynecol Cancer; 2012 Sep 15; 22(7):1138-42. PubMed ID: 22914212
    [Abstract] [Full Text] [Related]

  • 20. Changes in epidermal growth factor receptor and the levels of its ligands during menstrual cycle in human endometrium.
    Imai T, Kurachi H, Adachi K, Adachi H, Yoshimoto Y, Homma H, Tadokoro C, Takeda S, Yamaguchi M, Sakata M.
    Biol Reprod; 1995 Apr 15; 52(4):928-38. PubMed ID: 7540053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.